Paper Details 
Original Abstract of the Article :
Yellow fever vaccine was considered one of the safest vaccines, but in recent years it was found that it could rarely cause invasive and disseminated disease in some otherwise healthy individuals, with high lethality. After extensive studies, although some risk factors have been identified, the real...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635904/

データ提供:米国国立医学図書館(NLM)

Unveiling the Shadows of Yellow Fever Vaccine: Rare But Serious Adverse Events

Yellow fever vaccine, a guardian against this deadly disease, has long been considered a safe and effective tool in the fight against this viral menace. However, recent studies have revealed a hidden truth - it can also cause serious adverse events in some individuals. This unexpected twist, like a mirage in the desert, throws a new light on the safety of this vaccine.

The research delves into the mysterious world of these rare but severe adverse events, characterized by invasive and disseminated disease. While risk factors have been identified, the underlying causes remain a puzzle. The study points towards individual host factors as potential culprits. Meningoencephalitis, once thought to affect only infants, has been observed in older children and adults, though with a generally favorable prognosis.

Navigating the Shifting Sands of Vaccine Safety: A Quest for Safer Options

The researchers acknowledge the significance of these findings, highlighting the need for a safer yellow fever vaccine. An inactivated vaccine and a vaccine prepared with the virus envelope produced in plants are currently under investigation. It's a quest for a new oasis of safety and efficacy.

A Balancing Act: Weighing Risks and Benefits

Despite the potential for rare adverse events, the study emphasizes the importance of yellow fever vaccination. The benefits of protection against this deadly disease far outweigh the risks. This is like a traveler choosing to navigate a difficult path, knowing the reward of a safe haven at the end.

Dr. Camel's Conclusion

This research reminds us that even in the seemingly predictable landscape of vaccine safety, unexpected challenges can arise. However, like a seasoned desert traveler, we must continue to seek safer and more effective solutions. The quest for a safer yellow fever vaccine continues, driven by a desire to conquer this deadly disease while ensuring patient safety. It's a journey that requires both scientific rigor and a deep understanding of the intricate relationship between human health and the natural world.

Date :
  1. Date Completed 2016-05-16
  2. Date Revised 2023-11-04
Further Info :

Pubmed ID

26090855

DOI: Digital Object Identifier

PMC4635904

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.